KELLIE NIELSEN: Open Payments
NPI 1992154777 · BRIGHAM CITY, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$958 in 56 payments from 15 companies in 2025. Trend: 2023 $835 · 2024 $1,033 · 2025 $958
Food & beverage: $958
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $385 |
| Lundbeck LLC | 5 | $76 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $68 |
| Grifols USA, LLC | 3 | $67 |
| Amgen Inc. | 3 | $51 |
| Otsuka America Pharmaceutical, Inc. | 3 | $51 |
| Corcept Therapeutics | 2 | $49 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $39 |
| Exact Sciences Corporation | 2 | $37 |
| Alkermes, Inc. | 2 | $35 |
Products named: VRAYLAR, REXULTI, QULIPTA, TRINTELLIX, Prolastin-C Liquid, EVENITY, UBRELVY, Korlym.
Industry payments across UT — which companies pay providers there.
